menu
    • menu

    Company profile for Olpha

    Olpha-PSE
    News
    Olpha's Social Projects Earn Global Pharma Award Nomination

    24 Sep 2024

    // PRESS RELEASE

    Olpha will already be offering four new medicines on EU markets this year

    09 Jul 2024

    // PRESS RELEASE

    Olainfarm transforms into Olpha, aiming to become Europe’s TOP 10 pharmaceutical

    19 Jun 2024

    // PRESS RELEASE

    DATA COMPILATION
    #PharmaFlow

    Olpha

    Contact Supplier

    Website

    AES 2024

    Not Confirmed

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    https://www.youtube.com/embed/1Yfm_JmES_M

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INTERMEDIATES

    Key Products KEY PRODUCTS

    SERVICES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Olpha, a JSC AB City subsidiary, is a leading Baltic firm with 50 years of experience in medicines & chemical pharmaceuticals.

    Related CompaniesRelated Companies

    About

    Olpha, the subsidiary of JSC AB City, is one of the largest companies in the Baltic states with 50 years of experience in the production of medicines & chemical pharmaceutical products. The range of product portfolio developed by the company, includes 60 formulations, 25 APIs & >20 intermediates, including medicinal products for the nervous system, cardiovascular health, as well as antiviral, antibacterial & anti-allergic drugs. The health care products created by Olpha ensure both, the even more broader access of users to the necessary medicinal products, as well as the company’s growth & reputation in the global market.

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    OlphaLatvia Flag
    Country
    Country
    Latvia
    Address
    Address
    Rupnicu street 5, Olaine, Olaine District, LV-2114
    Telephone
    Telephone
    +371 67013705
    Client Email
    Email
    didzis.skards@olpha.eu
    Client Website
    Website
    https://olpha.eu/en/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/olphaglobal/
    youtube
    YouTube
    http://www.youtube.com/@Olphaglobal
    Twitter
    Twitter
    Contact Info
    Others

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    CPHI Middle east

    CPHI Middle east

    Not Confirmed

    envelop Contact Supplier

    CPHI Middle east

    Post an Enquiry

    Meeting

    Digital content read-more

    Explore the latest content creation from this company

    CORPORATE CONTENT #SupplierSpotlight

    Product List 2024

    read-more

      https://www.pharmacompass.com/pdf/party/content/olpha-party-content-29246.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    Corporate Presentation

    read-more

      https://www.pharmacompass.com/pdf/party/content/olpha-party-content-21772.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    FDF Product List 2024

    read-more

      https://www.pharmacompass.com/pdf/party/content/olpha-party-content-14571.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    GMP Certificate 2023

    read-more

      https://www.pharmacompass.com/pdf/party/content/jsc-olainfarm-party-content-14151.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    NEWS #PharmaBuzz

    read-more
    read-more
    Olpha's Social Projects Earn Global Pharma Award Nomination
    Olpha's Social Projects Earn Global Pharma Award Nomination

    24 Sep 2024

    // PRESS RELEASE

    https://olpha.eu/en/olphas-social-responsibility-projects-nominated-for-prestigious-international-pharmaceutical-award-2/

    PRESS RELEASE
    24 Sep 2024
    Share Share
    Olpha will already be offering four new medicines on EU markets this year
    Olpha will already be offering four new medicines on EU markets this year

    09 Jul 2024

    // PRESS RELEASE

    https://olpha.eu/en/olpha-will-already-be-offering-four-new-medicines-on-eu-markets-this-year-next-year-their-number-will-grow-to-at-least-20/

    PRESS RELEASE
    09 Jul 2024
    Share Share
    Olainfarm transforms into Olpha, aiming to become Europe’s TOP 10 pharmaceutical
    Olainfarm transforms into Olpha, aiming to become Europe’s TOP 10 pharmaceutical

    19 Jun 2024

    // PRESS RELEASE

    https://olpha.eu/en/olainfarm-transforms-into-olpha-aiming-to-become-europes-top-10-pharmaceutical-company/

    PRESS RELEASE
    19 Jun 2024
    Share Share
    Six young chemistry and biology teachers in Latvia are awarded scholarships of 18 000 euros
    Six young chemistry and biology teachers in Latvia are awarded scholarships of 18 000 euros

    03 May 2024

    // PRESS RELEASE

    https://lv.olainfarm.com/six-young-chemistry-and-biology-teachers-in-latvia-are-awarded-scholarships-of-18-000-euros/

    PRESS RELEASE
    03 May 2024
    Share Share
    Olainfarm has established subsidiaries in France, Italy, Spain, Germany and Poland; continues registration of new products in EU markets
    Olainfarm has established subsidiaries in France, Italy, Spain, Germany and Poland; continues registration of new products in EU markets

    17 Apr 2024

    // PRESS RELEASE

    https://lv.olainfarm.com/olainfarm-has-established-subsidiaries-in-france-italy-spain-germany-and-poland-continues-registration-of-new-products-in-eu-markets/

    PRESS RELEASE
    17 Apr 2024
    Share Share
    The fund of the scholarship “Chemistry Between Us!” has been increased to 135,000 euros; new chemistry and biology teachers are invited to apply
    The fund of the scholarship “Chemistry Between Us!” has been increased to 135,000 euros; new chemistry and biology teachers are invited to apply

    20 Mar 2024

    // PRESS RELEASE

    https://lv.olainfarm.com/the-fund-of-the-scholarship-chemistry-between-us-has-been-increased-to-135000-euros-new-chemistry-and-biology-teachers-are-invited-to-apply/

    PRESS RELEASE
    20 Mar 2024
    Share Share

    ALL APIs

    read-moreClick the button for full data set
    read-moreClick the button for full data set

    01

    Memantine Hydrochloride

    Latvia

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothOlpha, a JSC AB City subsidiary, is a leading Baltic firm with 50 years of experience in medicines & chemical pharmaceuticals.
    USDMF arrow-down Click Us! arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2013-02-07

    Pay. Date : 2012-11-27

    DMF Number : 20543

    Submission : 2007-05-09

    Status : Active

    Type : II

     CEP/COS JDMF arrow-down
    ✖

    Registration Number : 230MF10048

    Registrant's Address : 5 Rupnicu Street, Olain, LV-2114, Latvia

    Initial Date of Registration : 2018-03-30

    Latest Date of Registration :

    EU-WC NDC arrow-down
    ✖

    NDC Package Code : 63818-0004

    Start Marketing Date : 2016-05-05

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT FOR ...

    KDMF arrow-down
    ✖

    Registrant Name : Eltek Pharmachem Co., Ltd.

    Registration Date : 2020-05-22

    Registration Number : 20200522-209-J-377

    Manufacturer Name : JSC OlainFarm

    Manufacturer Address : 5, Rupnicu Street, Olaine, LV-2114, Latvia

     VMF ASMF arrow-down
    ✖
    Available Reg. Filing : ASMF
    AUDIT
    Olpha

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    Amantadine Hydrochloride

    Latvia

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothOlpha, a JSC AB City subsidiary, is a leading Baltic firm with 50 years of experience in medicines & chemical pharmaceuticals.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2013-11-20

    Pay. Date : 2012-11-27

    DMF Number : 23528

    Submission : 2010-02-11

    Status : Active

    Type : II

     CEP/COS JDMF EU-WC NDC arrow-down
    ✖

    NDC Package Code : 63818-0435

    Start Marketing Date : 2016-05-05

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT FOR ...

    KDMF VMF ASMF arrow-down
    ✖
    Available Reg. Filing : ASMF
    AUDIT
    Olpha

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    Anagrelide Hydrochloride

    Latvia

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothOlpha, a JSC AB City subsidiary, is a leading Baltic firm with 50 years of experience in medicines & chemical pharmaceuticals.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 17041

    Submission : 2003-12-16

    Status : Active

    Type : II

     CEP/COS JDMF EU-WC NDC arrow-down
    ✖

    NDC Package Code : 63818-0425

    Start Marketing Date : 2017-07-13

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT FOR ...

    KDMF VMF Others AUDIT
    Olpha

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    04

    Memantine Hydrochloride

    Latvia

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothOlpha, a JSC AB City subsidiary, is a leading Baltic firm with 50 years of experience in medicines & chemical pharmaceuticals.
    USDMF CEP/COS